COVID-19 virus-human protein network provides new tools and strategies for screening host-targeting therapies
Researchers used artificial intelligence to map out hundreds of ways that the virus that causes COVID-19 interacts with infected cells. Through this analysis, they identified potential COVID-19 medicines within thousands of drugs already approved by the FDA for other treatments.